MSS/ MMRp
Quiénes somos
Terapia celular NKG2D CAR-NK en pacientes con cáncer colorrectal metastásico refractario
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer (BREAKWATER)
Trial Of Pembrolizumab And Nintedanib
Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer
Ensayo COLLISION - Metástasis hepáticas colorrectales: Cirugía frente a ablación térmica
La combinación de fruquintinib, tislelizumab y radioterapia ablativa estereotáctica en el cáncer colorrectal metastásico (RIFLE)
Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer
Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.
The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
